Notably, the tumor-specific expression pattern of SAGE1 has been found in several solid cancers, e.g., bladder cancer, lung cancer, and head and neck cancer, highlighting its role as a potential target for cancer immunotherapy [28]. This evidence concerns the gene SAGE1 and lung carcinoma.